Project 2: Identifying Metabolic vulnerabilities and targets in cancers with mutations in hamartoma genes
- Institution
- BRIGHAM AND WOMEN'S HOSPITAL, MA
- Principal investigator
- David J. Kwiatkowski
- Funding
- $552K
- Duration
- 2007–2028
Moonbase score
Still being scored
Abstract
Project 2: Abstract The hypothesis guiding this proposal is that mutations in hamartoma syndrome genes (PTEN, LKB1, TSC1, TSC2) dominantly rewire metabolism exposing unique vulnerabilities. The focus of this project is to better understand the molecular and biochemical basis for the metabolic vulnerabilities and provide preclinical data that would support the development of biomarker driven clinical trials to evaluate such drugs in patients with germline or the many tumors containing sporadic mutations in hamartoma syndrome genes. We have decoded the optimal substrate motif for every single mammalian protein kinase in the last funding period and made an algorithm that allows us to decode which kinases are active or inactive in a given biological samples based on unbiased phospho-proteomics. Here we will focus on use of this new method to identify new metabolic enzymes targeted by LKB1-dependent kinases. The specific aims are: 1) Defining critical kinase- substrate interactions deregulated in hamartoma genes in cell lines and tissues; 2) Defining metabolic vulnerabilities deregulated in hamartoma genes in cell lines and tissues; and 3) Defining how AMPK control of TFEB contributes to the survival of hamartoma cells and how to target tumors based on new understanding of this pathway.
LOADING MOONBASE SCORE
Questions for BRIGHAM AND WOMEN'S HOSPITAL
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Brigham and Women'S HospitalNot yet scored
Molecular Pathogenesis of the Hamartoma Syndromes
David J. Kwiatkowski · $2.1M · 2007–2028
- NIH · Brigham and Women'S HospitalNot yet scored
Project 1: Identifying new therapeutic avenues to selectively target tumors with uncontrolled mTORC1 activation
David J. Kwiatkowski · $493K · 2007–2028
- NIH · Brigham and Women'S HospitalNot yet scored
Project 3: Identifying transcriptional driver genes and targeting transcription in TSC
David J. Kwiatkowski · $777K · 2007–2028